CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 7, 2006--ARIAD Pharmaceuticals, Inc. (Nasdaq: ARIA) today announced consolidated financial results for the quarter and the year ended December 31, 2005 and provided product development goals and financial guidance for 2006.
